The Reporter Gene Assay Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the reporter gene assay has seen significant growth historically. It is expected to expand from $6.39 billion in 2024 to $6.99 billion in 2025, with a compound annual growth rate (CAGR) of 9.3%.
The Reporter Gene Assay market is expected to reach $9.84 billion in 2029, with a compound annual growth rate (CAGR) of 8.9%.
Download Your Free Sample of the 2025 Reporter Gene Assay Market Report and Uncover Key Trends Now!The drivers in the reporter gene assay market are:
• Rising demand for cell-based assays
• Increase in genomics research activities
• Growth in drug discovery and development research
• Increased need for personalized treatment and early diagnosis
The reporter gene assay market covered in this report is segmented –
1) By Product: Assay Kits, Reagents
2) By Application: Promoter Structural And Functional Analysis, Cell Signaling Pathways, Protein Interaction, Clinical And Gene Regulation
3) By End-User: Biotechnology And Pharmaceutical Companies, Research And Academic Institutes, Hospital And Diagnostic Laboratories, Contract Research Organizations
The trends in the reporter gene assay market are:
• Technological advancements in gene therapy are becoming a prominent trend in the Reporter Gene Assay market.
• There's an emerging trend of advancements in molecular biology.
• The demand for advanced molecular diagnostic tools is another future trend.
• A shift towards 3D cell culture models and strategic partnerships is also shaping the market's future.
The major players in the reporter gene assay market are:
• Roche Diagnostics
• Thermo Fisher Scientific
• Danaher Corporation
• Merck KGaA
• Becton Dickinson and Company (BD Biosciences)
• GE Healthcare
•
North America was the largest region in the reporter gene assay market in 2024